News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Europeans, U.S. Disagree Over Safety Of Ranbaxy Laboratories (RANBAXY.BO) Facility



6/6/2014 7:15:32 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

European regulators said on Thursday they have completed their assessment of drug manufacturing violations at Ranbaxy Laboratories Ltd's facility in Toansa, India, and although deficiencies were found, they pose no risk to public health. The regulators said they were satisfied by corrective measures put in place by the company after U.S. regulators found deviations in January. The assessment stands in stark contrast to the response of U.S. regulators to the deficiencies found at the plant.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Money Control
Read at Live Mint
Read at Wall Street Journal


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES